PROVIDE A UNIQUE PROFESSIONAL SERVICE
By offering myDNA in your pharmacy, you can now provide a more personalised service to your customers.
The myDNA Medication tests use pharmacogenomics to identify variations in a number of genes that influence medication response.
Currently, myDNA Medication reports concentrate on the genes encoding the metabolising enzymes (i.e. CYP450 enzymes) which are found mainly in the liver as well as the gut wall. These genetic variations predict the level of enzyme activity which in turn results in increased or decreased plasma concentrations and drug exposure.
Increased plasma concentrations, due to reduced enzyme activity, can lead to adverse effects. Reduced plasma concentrations, due to increased enzyme activity, can lead to poor therapeutic response.
myDNA offers a multiple gene medication test, which covers multiple medication categories (currently in excess of 80 medications). If information on medications in a specific therapeutic area is of interest, myDNA offers four single category medication reports as shown below.
Enzyme function can also be affected by factors other than genotype, including age, the effect of co-administered drugs (i.e. drug-drug interactions), and the presence of liver disease. These should be taken into account when considering the myDNA Medication Reports.
Reports must be delivered by a suitable healthcare professional. myDNA provides training for medical staff to assist in the understanding of these reports. If you would like to know more about this training, please email us: [email protected].
Each person who takes a myDNA test will receive a highly customised medication report and ongoing access to their Explore myDNA – a secure online portal that provides information relevant to the person’s genetic profile.
In our reports, myDNA references the guidelines of the Royal Dutch Pharmacists Association – Pharmacogenetics Pharmacogenomics Working Group and the Clinical Pharmacogenetics Implementation Consortium (CPIC). Generally, the emphasis is on CPIC guidelines, given their more recent publication.
The following published guidelines contain evidence for gene-drug associations for which dosage adjustments have been recommended. These can be accessed online at CPIC.
myDNA was the first to offer pharmacogenomic testing in Australian pharmacies in 2015. Today it is available in more than 1,000 pharmacies nationwide.
Participating pharmacies are at the forefront of personalised medicine and are able to provide an enhanced service to their customers.
PROVIDE TREATMENT OUTCOMES
BUILD STRONGER RELATIONSHIPS
OFFER A PERSONALISED
PROVIDE A POINT OF DIFFERENCE
ENCOURAGE PROFESSIONAL DEVELOPMENT
Offering the myDNA program in your pharmacy is simple. Each pharmacy’s program manager nominates staff members who undertake comprehensive myDNA training.
We have helpful support staff and a clinical team if you ever require any assistance along the way.
Call us on 1300 436 373
Rachel shares her story
Joy shares her story
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.